Challenges in the use of nanostructures as carriers of nucleic acids in clinical practice.

Bibliographic Details
Main Author: QUINTAO, C. C. R.
Publication Date: 2022
Other Authors: CAMARGO, L. S. de A., BRANDAO, H. de M., SARAIVA, N. Z., MUNK, M.
Format: Article
Language: eng
Source: Repositório Institucional da EMBRAPA (Repository Open Access to Scientific Information from EMBRAPA - Alice)
Download full: http://www.alice.cnptia.embrapa.br/alice/handle/doc/1142832
https://doi.org/10.31744/einstein_journal/2022RB5898
Summary: The delivery of nucleic acids to cells is considered a crucial step for the success of genetic modifications aimed at therapeutic purposes or production of genetically modified animals. In this context, nanotechnology is one of the most promising fields of science, with the potential to solve several existing problems. Nanostructures have desirable characteristics to be used as carriers, such as nanometric size, large surface area, cell internalization capacity, prolonged and controlled release, among others. Genetically modified animals can contribute to the production of biopharmaceuticals, through the expression of high-associated-value molecules. The production of these animals, also known as biofactories, further enhances Brazilian agribusiness, since it allows adding value to the final product, and favors the integration between the agricultural market and the pharmaceutical sector. However, there is a growing concern about the safety and possible harmful effects of nanostructures, since data on the safe use of these materials are still insufficient. The objective of this review was to address aspects of the use of nanostructures, mainly carbon nanotubes as nucleic acid carriers, aiming at the production of genetically modified animals, with the certainty that progress in this field of knowledge depends on more information on the mechanisms of interaction between nanostructures, cells and embryos, as well as on its toxicity.
id EMBR_5469e6a2008fafca91e8cdbcaef5fd7a
oai_identifier_str oai:www.alice.cnptia.embrapa.br:doc/1142832
network_acronym_str EMBR
network_name_str Repositório Institucional da EMBRAPA (Repository Open Access to Scientific Information from EMBRAPA - Alice)
repository_id_str 2154
spelling Challenges in the use of nanostructures as carriers of nucleic acids in clinical practice.NanoestruturaNanotubo de carbonoGenetically modifiedNanotecnologiaÁcido NucléicoMelhoramento Genético AnimalGenética AnimalNucleic acidsEmbryonic structuresNanotubesThe delivery of nucleic acids to cells is considered a crucial step for the success of genetic modifications aimed at therapeutic purposes or production of genetically modified animals. In this context, nanotechnology is one of the most promising fields of science, with the potential to solve several existing problems. Nanostructures have desirable characteristics to be used as carriers, such as nanometric size, large surface area, cell internalization capacity, prolonged and controlled release, among others. Genetically modified animals can contribute to the production of biopharmaceuticals, through the expression of high-associated-value molecules. The production of these animals, also known as biofactories, further enhances Brazilian agribusiness, since it allows adding value to the final product, and favors the integration between the agricultural market and the pharmaceutical sector. However, there is a growing concern about the safety and possible harmful effects of nanostructures, since data on the safe use of these materials are still insufficient. The objective of this review was to address aspects of the use of nanostructures, mainly carbon nanotubes as nucleic acid carriers, aiming at the production of genetically modified animals, with the certainty that progress in this field of knowledge depends on more information on the mechanisms of interaction between nanostructures, cells and embryos, as well as on its toxicity.CAROLINA CAPOBIANGO ROMANO QUINTAO, CNPGL; LUIZ SERGIO DE ALMEIDA CAMARGO, CNPGL; HUMBERTO DE MELLO BRANDAO, CNPGL; NAIARA ZOCCAL SARAIVA, CNPGL; MICHELE MUNK, Universidade Federal de Juiz de Fora.QUINTAO, C. C. R.CAMARGO, L. S. de A.BRANDAO, H. de M.SARAIVA, N. Z.MUNK, M.2022-05-10T16:12:42Z2022-05-10T16:12:42Z2022-05-102022info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleEinstein, v. 20, eRB5898, 2022.http://www.alice.cnptia.embrapa.br/alice/handle/doc/1142832https://doi.org/10.31744/einstein_journal/2022RB5898enginfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da EMBRAPA (Repository Open Access to Scientific Information from EMBRAPA - Alice)instname:Empresa Brasileira de Pesquisa Agropecuária (Embrapa)instacron:EMBRAPA2022-05-10T16:12:50Zoai:www.alice.cnptia.embrapa.br:doc/1142832Repositório InstitucionalPUBhttps://www.alice.cnptia.embrapa.br/oai/requestopendoar:21542022-05-10T16:12:50falseRepositório InstitucionalPUBhttps://www.alice.cnptia.embrapa.br/oai/requestcg-riaa@embrapa.bropendoar:21542022-05-10T16:12:50Repositório Institucional da EMBRAPA (Repository Open Access to Scientific Information from EMBRAPA - Alice) - Empresa Brasileira de Pesquisa Agropecuária (Embrapa)false
dc.title.none.fl_str_mv Challenges in the use of nanostructures as carriers of nucleic acids in clinical practice.
title Challenges in the use of nanostructures as carriers of nucleic acids in clinical practice.
spellingShingle Challenges in the use of nanostructures as carriers of nucleic acids in clinical practice.
QUINTAO, C. C. R.
Nanoestrutura
Nanotubo de carbono
Genetically modified
Nanotecnologia
Ácido Nucléico
Melhoramento Genético Animal
Genética Animal
Nucleic acids
Embryonic structures
Nanotubes
title_short Challenges in the use of nanostructures as carriers of nucleic acids in clinical practice.
title_full Challenges in the use of nanostructures as carriers of nucleic acids in clinical practice.
title_fullStr Challenges in the use of nanostructures as carriers of nucleic acids in clinical practice.
title_full_unstemmed Challenges in the use of nanostructures as carriers of nucleic acids in clinical practice.
title_sort Challenges in the use of nanostructures as carriers of nucleic acids in clinical practice.
author QUINTAO, C. C. R.
author_facet QUINTAO, C. C. R.
CAMARGO, L. S. de A.
BRANDAO, H. de M.
SARAIVA, N. Z.
MUNK, M.
author_role author
author2 CAMARGO, L. S. de A.
BRANDAO, H. de M.
SARAIVA, N. Z.
MUNK, M.
author2_role author
author
author
author
dc.contributor.none.fl_str_mv CAROLINA CAPOBIANGO ROMANO QUINTAO, CNPGL; LUIZ SERGIO DE ALMEIDA CAMARGO, CNPGL; HUMBERTO DE MELLO BRANDAO, CNPGL; NAIARA ZOCCAL SARAIVA, CNPGL; MICHELE MUNK, Universidade Federal de Juiz de Fora.
dc.contributor.author.fl_str_mv QUINTAO, C. C. R.
CAMARGO, L. S. de A.
BRANDAO, H. de M.
SARAIVA, N. Z.
MUNK, M.
dc.subject.por.fl_str_mv Nanoestrutura
Nanotubo de carbono
Genetically modified
Nanotecnologia
Ácido Nucléico
Melhoramento Genético Animal
Genética Animal
Nucleic acids
Embryonic structures
Nanotubes
topic Nanoestrutura
Nanotubo de carbono
Genetically modified
Nanotecnologia
Ácido Nucléico
Melhoramento Genético Animal
Genética Animal
Nucleic acids
Embryonic structures
Nanotubes
description The delivery of nucleic acids to cells is considered a crucial step for the success of genetic modifications aimed at therapeutic purposes or production of genetically modified animals. In this context, nanotechnology is one of the most promising fields of science, with the potential to solve several existing problems. Nanostructures have desirable characteristics to be used as carriers, such as nanometric size, large surface area, cell internalization capacity, prolonged and controlled release, among others. Genetically modified animals can contribute to the production of biopharmaceuticals, through the expression of high-associated-value molecules. The production of these animals, also known as biofactories, further enhances Brazilian agribusiness, since it allows adding value to the final product, and favors the integration between the agricultural market and the pharmaceutical sector. However, there is a growing concern about the safety and possible harmful effects of nanostructures, since data on the safe use of these materials are still insufficient. The objective of this review was to address aspects of the use of nanostructures, mainly carbon nanotubes as nucleic acid carriers, aiming at the production of genetically modified animals, with the certainty that progress in this field of knowledge depends on more information on the mechanisms of interaction between nanostructures, cells and embryos, as well as on its toxicity.
publishDate 2022
dc.date.none.fl_str_mv 2022-05-10T16:12:42Z
2022-05-10T16:12:42Z
2022-05-10
2022
dc.type.driver.fl_str_mv info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv Einstein, v. 20, eRB5898, 2022.
http://www.alice.cnptia.embrapa.br/alice/handle/doc/1142832
https://doi.org/10.31744/einstein_journal/2022RB5898
identifier_str_mv Einstein, v. 20, eRB5898, 2022.
url http://www.alice.cnptia.embrapa.br/alice/handle/doc/1142832
https://doi.org/10.31744/einstein_journal/2022RB5898
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.source.none.fl_str_mv reponame:Repositório Institucional da EMBRAPA (Repository Open Access to Scientific Information from EMBRAPA - Alice)
instname:Empresa Brasileira de Pesquisa Agropecuária (Embrapa)
instacron:EMBRAPA
instname_str Empresa Brasileira de Pesquisa Agropecuária (Embrapa)
instacron_str EMBRAPA
institution EMBRAPA
reponame_str Repositório Institucional da EMBRAPA (Repository Open Access to Scientific Information from EMBRAPA - Alice)
collection Repositório Institucional da EMBRAPA (Repository Open Access to Scientific Information from EMBRAPA - Alice)
repository.name.fl_str_mv Repositório Institucional da EMBRAPA (Repository Open Access to Scientific Information from EMBRAPA - Alice) - Empresa Brasileira de Pesquisa Agropecuária (Embrapa)
repository.mail.fl_str_mv cg-riaa@embrapa.br
_version_ 1794503522574663680